Literature DB >> 21640733

The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors.

Matt T Bianchi1, Alison G Clark, Janet L Fisher.   

Abstract

Histamine is an important wake-promoting neurotransmitter that activates seven-transmembrane G-protein coupled histamine receptors. However, histamine demonstrates target promiscuity, including direct interaction with the structurally unrelated glutamate (NMDA) and GABA(A) receptor channels. Previous work showed that histamine enhances the activity of recombinant GABA(A) receptor isoforms typically found in synaptic locations, although co-release of histamine and GABA is not known to occur in vivo. Here we used patch clamp recordings of various recombinant GABA(A) receptor isoforms (α1-6, β1-3, γ1-3, δ) to test the hypothesis that histamine might show subunit preference under low GABA concentration (extrasynaptic) conditions. We found that histamine potentiated the whole-cell responses to GABA for all tested subunit combinations. However, the magnitude of enhancement was largest (∼400% of EC(10) GABA-evoked currents) with α4β3 and α4β3X isoforms, where X could be γ or δ. In contrast, histamine (1 mM) had small effects on prolonging deactivation of α4β3γ2 receptors following brief (5 ms) pulses of 1 mM GABA. These findings suggest GABA-histamine cross-talk may occur preferentially at low GABA concentrations, which could theoretically be inhibitory (via enhancing tonic inhibition), directly excitatory (via enhancing presynaptic GABAergic signaling), or indirectly excitatory (via inhibiting GABAergic interneurons).
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640733      PMCID: PMC3679895          DOI: 10.1016/j.neuropharm.2011.05.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  69 in total

1.  GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.

Authors:  S Pirker; C Schwarzer; A Wieselthaler; W Sieghart; G Sperk
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Understanding wiring and volume transmission.

Authors:  Luigi F Agnati; Diego Guidolin; Michele Guescini; Susanna Genedani; Kjell Fuxe
Journal:  Brain Res Rev       Date:  2010-03-27

3.  Histamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized rats.

Authors:  N Sittig; H Davidowa
Journal:  Behav Brain Res       Date:  2001-10-15       Impact factor: 3.332

4.  Neuronal storage of histamine in the brain and tele-methylimidazoleacetic acid excretion in portocaval shunted rats.

Authors:  W A Fogel; K A Michelsen; G Granerus; K Sasiak; W Andrzejewski; P Panula; C Maslinski
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

5.  Ionotropic histamine receptors and H2 receptors modulate supraoptic oxytocin neuronal excitability and dye coupling.

Authors:  G I Hatton; Q Z Yang
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons.

Authors:  D Bai; G Zhu; P Pennefather; M F Jackson; J F MacDonald; B A Orser
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

7.  The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro.

Authors:  Leanne Coyne; George Lees; Russell A Nicholson; Jian Zheng; Katherine D Neufield
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

8.  Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity?

Authors:  Matt T Bianchi; Emmanuel J Botzolakis
Journal:  BMC Pharmacol       Date:  2010-03-02

9.  Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

Authors:  N Brown; J Kerby; T P Bonnert; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Behavioral characterization of mice lacking histamine H(3) receptors.

Authors:  Hiroshi Toyota; Christine Dugovic; Muriel Koehl; Aaron D Laposky; China Weber; Karen Ngo; Ying Wu; Doo Hyun Lee; Kazuhiko Yanai; Eiko Sakurai; Takehiko Watanabe; Changlu Liu; Jingcai Chen; Ann J Barbier; Fred W Turek; Wai-Ping Fung-Leung; Timothy W Lovenberg
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

View more
  5 in total

1.  Histamine H3 Receptor Antagonist Prevents Memory Deficits and Synaptic Plasticity Disruption Following Isoflurane Exposure.

Authors:  Tao Luo; Ying Wang; Jian Qin; Zhi-Gang Liu; Min Liu
Journal:  CNS Neurosci Ther       Date:  2017-02-06       Impact factor: 5.243

2.  Differential assembly diversifies GABAA receptor structures and signalling.

Authors:  Andrija Sente; Rooma Desai; Katerina Naydenova; Tomas Malinauskas; Youssef Jounaidi; Jonas Miehling; Xiaojuan Zhou; Simonas Masiulis; Steven W Hardwick; Dimitri Y Chirgadze; Keith W Miller; A Radu Aricescu
Journal:  Nature       Date:  2022-03-30       Impact factor: 69.504

3.  Identification of amino acids involved in histamine potentiation of GABA A receptors.

Authors:  Ulrike Thiel; Sarah J Platt; Steffen Wolf; Hanns Hatt; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2015-05-26       Impact factor: 5.810

4.  Wakefulness Is Governed by GABA and Histamine Cotransmission.

Authors:  Xiao Yu; Zhiwen Ye; Catriona M Houston; Anna Y Zecharia; Ying Ma; Zhe Zhang; David S Uygun; Susan Parker; Alexei L Vyssotski; Raquel Yustos; Nicholas P Franks; Stephen G Brickley; William Wisden
Journal:  Neuron       Date:  2015-06-18       Impact factor: 17.173

Review 5.  The role of co-neurotransmitters in sleep and wake regulation.

Authors:  Jun Oh; Cathrine Petersen; Christine M Walsh; Jackson C Bittencourt; Thomas C Neylan; Lea T Grinberg
Journal:  Mol Psychiatry       Date:  2018-10-30       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.